Principal Financial Group’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.4K Buy
17,141
+5,383
+46% +$10.5K ﹤0.01% 2202
2025
Q1
$20.7K Buy
11,758
+1,619
+16% +$2.85K ﹤0.01% 2146
2024
Q4
$27K Sell
10,139
-2,363
-19% -$6.29K ﹤0.01% 2189
2024
Q3
$28.6K Sell
12,502
-13,448
-52% -$30.8K ﹤0.01% 2202
2024
Q2
$75.8K Buy
25,950
+9,603
+59% +$28K ﹤0.01% 2244
2024
Q1
$59.5K Sell
16,347
-1,198
-7% -$4.36K ﹤0.01% 2330
2023
Q4
$26.5K Sell
17,545
-2,906
-14% -$4.39K ﹤0.01% 2375
2023
Q3
$27.4K Buy
20,451
+4,983
+32% +$6.68K ﹤0.01% 2390
2023
Q2
$27.8K Sell
15,468
-33,245
-68% -$59.8K ﹤0.01% 2399
2023
Q1
$80.9K Buy
48,713
+3,500
+8% +$5.81K ﹤0.01% 2328
2022
Q4
$86.8K Buy
45,213
+8,296
+22% +$15.9K ﹤0.01% 2319
2022
Q3
$82K Buy
36,917
+6,395
+21% +$14.2K ﹤0.01% 2364
2022
Q2
$99K Sell
30,522
-20,537
-40% -$66.6K ﹤0.01% 2393
2022
Q1
$268K Buy
51,059
+181
+0.4% +$950 ﹤0.01% 2267
2021
Q4
$433K Buy
50,878
+38,208
+302% +$325K ﹤0.01% 2160
2021
Q3
$126K Buy
+12,670
New +$126K ﹤0.01% 2480